A study in humans demonstrated that the miR-2861 was significantly upregulated in the plasma of patients with mild, moderate, and severe traumatic brain injury (TBI) compared to healthy controls, as validated by RT-qPCR [Qin et al. DOI:10.1371/journal.pone.0204051].